Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanti R Rai

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Best Practice & Research. Clinical Haematology|July 13, 2010
Where do we go from here?Kanti R Rai
Clinical Lymphoma|November 19, 2002
Campath-1H for chronic lymphocytic leukemiaKanti R Rai
Best Practice & Research. Clinical Haematology|August 21, 2007
Introduction: Chronic lymphocytic leukemia in perspectiveKanti R Rai
Journal of Hematology & Oncology|July 15, 2015
Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemiaKanti R Rai
Clinical Advances in Hematology & Oncology : H&O|June 27, 2008
The natural history of CLL and new prognostic markersKanti R Rai
Seminars in Hematology|July 23, 2004
Exciting new developments in chronic lymphocytic leukemia: an introduction and an editorialKanti R Rai
Experimental Hematology|March 24, 2007
Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapyKanti R Rai
Seminars in Oncology|May 25, 2006
Novel therapeutic strategies with alemtuzumab for chronic lymphocytic leukemiaKanti R Rai
Therapeutics and Clinical Risk Management|August 30, 2008
Alemtuzumab in the up-front settingMatthew Kaufman, Kanti R Rai
American Journal of Hematology|December 23, 2015
Chronic lymphocytic leukemia (CLL)-Then and nowKanti R Rai, Preetesh Jain
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Best Practice & Research. Clinical Haematology|July 13, 2010
Where do we go from here?Kanti R Rai
Clinical Lymphoma|November 19, 2002
Campath-1H for chronic lymphocytic leukemiaKanti R Rai
Best Practice & Research. Clinical Haematology|August 21, 2007
Introduction: Chronic lymphocytic leukemia in perspectiveKanti R Rai
Journal of Hematology & Oncology|July 15, 2015
Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemiaKanti R Rai
Clinical Advances in Hematology & Oncology : H&O|June 27, 2008
The natural history of CLL and new prognostic markersKanti R Rai
Seminars in Hematology|July 23, 2004
Exciting new developments in chronic lymphocytic leukemia: an introduction and an editorialKanti R Rai
Experimental Hematology|March 24, 2007
Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapyKanti R Rai
Seminars in Oncology|May 25, 2006
Novel therapeutic strategies with alemtuzumab for chronic lymphocytic leukemiaKanti R Rai
Therapeutics and Clinical Risk Management|August 30, 2008
Alemtuzumab in the up-front settingMatthew Kaufman, Kanti R Rai
American Journal of Hematology|December 23, 2015
Chronic lymphocytic leukemia (CLL)-Then and nowKanti R Rai, Preetesh Jain
Pageof 13